CPB
42
-3
BRK.B
47
-3
DGX
46
-2
PX
15
2
JCI
49
2
SRE
52
2
MAC
71
4
XEL
53
-5
WRK
59
3
IP
33
3
VNO
60
-3
CAG
47
3
VRSN
48
-5
MSFT
60
5
BWA
50
9
LMT
55
-5
EL
52
4
TROW
58
10
AVB
62
-2
DO
58
6
CPB
42
-3
BRK.B
47
-3
DGX
46
-2
PX
15
2
JCI
49
2
SRE
52
2
MAC
71
4
XEL
53
-5
WRK
59
3
IP
33
3
VNO
60
-3
CAG
47
3
VRSN
48
-5
MSFT
60
5
BWA
50
9
LMT
55
-5
EL
52
4
TROW
58
10
AVB
62
-2
DO
58
6
Financhill
Back

Adverum Biotechnologies 10K Form

Sell
8

ADVM
Adverum Biotechnologies

Last Price:
9.20
Seasonality Move:
13.31%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ADVM News And Ratings

See the #1 stock for the next 7 days that we like better than ADVM

ADVM Financial Statistics

Sales & Book Value

Annual Sales: $3.6M
Cash Flow: $-21.52M
Price / Cash Flow: 0
Annual Sales: $8.23
Price / Book: 2.29

Profitability

EPS (TTM): -11.60000
Net Income (TTM): $-117.17M
Gross Margin: $480K
Return on Equity: 0%
Return on Assets: 0%

Adverum Biotechnologies Earnings Forecast

Key Adverum Biotechnologies Financial Ratios

  • The Gross Profit Margin over the past 1 years for ADVM is 100.00%.
  • The Selling, General & Administrative Expenses for ADVM have been equal to 1,386.53% of Gross Profit Margin.
  • The Research & Development expenses have been 2,157.67% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of ADVM is -3,254.58% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 5 years.

Adverum Biotechnologies Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ADVM
CUSIP: 00773U
Website: adverum.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ADVM Technical Analysis vs Fundamental Analysis

Sell
8
Adverum Biotechnologies (ADVM) is a Sell

Is Adverum Biotechnologies a Buy or a Sell?